{"id":"W4200028620","doi":"10.1016/s1470-2045(21)00589-1","title":"Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients","year":2021,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":437,"is_retracted":false,"has_abstract":true,"ca_institutions":"Occupational Cancer Research Centre; Ontario Institute for Cancer Research","funders":"National Institute of General Medical Sciences; Cancer Prevention and Research Institute of Texas; Genentech; National Institutes of Health; Instituto de Investigación Sanitaria Gregorio Marañón; Bristol-Myers Squibb; Max-Planck-Gesellschaft; Eisai; National Institute for Health and Care Research; University of California, San Francisco; Cancer Research UK; Puma Biotechnology; Syndax Pharmaceuticals; Daiichi Sankyo Europe; National Cancer Institute; Gilead Sciences; PharmaMar; Celgene; Intas Pharmaceuticals; Eli Lilly and Company; AstraZeneca; European Regional Development Fund; Breast Cancer Research Foundation; Instituto de Salud Carlos III; Amgen; Pfizer","keywords":"Pooled analysis; Chemotherapy; Breast cancer; Cancer; Survival analysis; Meta-analysis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02127586,0.001404097,0.004720197,0.003124346,0.000454181,0.002057953,0.00119068,0.001263465,0.001191718],"category_scores_gemma":[0.02236384,0.0009535103,0.01292708,0.004375449,0.0005115847,0.0008530762,0.002065856,0.0006344435,0.0002844957],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009332982,"about_ca_system_score_gemma":0.001161705,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004100165,"about_ca_topic_score_gemma":0.004892857,"domain_scores_codex":[0.9853806,0.007152481,0.002870692,0.00269382,0.001307231,0.0005951949],"domain_scores_gemma":[0.981962,0.00606199,0.006166159,0.003851879,0.001490414,0.0004675595],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0153556,0.0001152271,0.7311625,0.00344053,0.2323428,0.0002458664,0.000349627,0.002515849,0.001013286,0.0001015326,0.001488987,0.01186821],"study_design_scores_gemma":[0.001665253,0.00171011,0.8110499,0.0004848667,0.1795949,0.0004265049,0.0002355761,0.001804039,0.0005403305,0.0002591713,0.002118542,0.0001107347],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9353107,0.04626769,0.004978623,0.000241656,0.0001810538,0.0003647047,0.01187774,0.0001185193,0.0006593116],"genre_scores_gemma":[0.9898078,0.002399403,0.001275257,0.0001539501,0.00008958845,0.0003731975,0.005679379,0.00003345787,0.0001880573],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02127586,"threshold_uncertainty_score":0.1125188,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01283719424098698,"score_gpt":0.3124301090058624,"score_spread":0.2995929147648754,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}